These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7614731)

  • 21. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
    Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
    Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the binding of C1q to immune complexes by zinc.
    Easterbrook-Smith SB
    FEBS Lett; 1983 Oct; 162(1):117-9. PubMed ID: 6604665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes.
    Gorgani NN; Parish CR; Easterbrook Smith SB; Altin JG
    Biochemistry; 1997 Jun; 36(22):6653-62. PubMed ID: 9184145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune complex mediated activation of the classical complement pathway.
    Borsos T
    Behring Inst Mitt; 1989 Jul; (84):93-101. PubMed ID: 2478118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci.
    Langone JJ
    Adv Immunol; 1982; 32():157-252. PubMed ID: 7051784
    [No Abstract]   [Full Text] [Related]  

  • 26. Complementing antibody profiles: assessing antibody function on antigen microarrays.
    Prechl J; Szittner Z; Papp K
    Immunol Lett; 2012 Mar; 143(1):101-5. PubMed ID: 22306105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of subcomponent C1q and collagen with isolated platelet membranes in platelet aggregation.
    Csákó G; Suba EA; Ohanian SH
    Haemostasis; 1983; 13(5):288-93. PubMed ID: 6606597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human blood platelets possess specific binding sites for C1q.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1987 Mar; 138(5):1537-41. PubMed ID: 3492557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of normal human serum on the binding of specific antibodies and platelet-unrelated immune complexes to human platelets.
    Kekomäki R; Myllylä G
    Scand J Immunol; 1979; 9(6):527-35. PubMed ID: 462123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhibition of platelet aggregation by immune complexes. I. Clinical studies].
    Shkhvatsabaia IK; Osipov SG; Turlubekov KK; Titov VN; Kasatkina LV
    Biull Eksp Biol Med; 1982 Nov; 94(11):27-9. PubMed ID: 7150731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a putative B cell superantigen on complement.
    Kozlowski LM; Lambris JD; Levinson AI
    Ann N Y Acad Sci; 1995 Sep; 764():356-8. PubMed ID: 7486545
    [No Abstract]   [Full Text] [Related]  

  • 32. C1q, antibodies and anti-C1q autoantibodies.
    Beurskens FJ; van Schaarenburg RA; Trouw LA
    Mol Immunol; 2015 Nov; 68(1):6-13. PubMed ID: 26032012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.
    Stümer J; Biermann MHC; Knopf J; Magorivska I; Kastbom A; Svärd A; Janko C; Bilyy R; Schett G; Sjöwall C; Herrmann M; Muñoz LE
    Clin Exp Immunol; 2017 Sep; 189(3):372-382. PubMed ID: 28509333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of ligand-binding sites on human C1q globular head region using recombinant globular head fragments and single-chain antibodies.
    Kojouharova MS; Tsacheva IG; Tchorbadjieva MI; Reid KB; Kishore U
    Biochim Biophys Acta; 2003 Nov; 1652(1):64-74. PubMed ID: 14580997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional characterization of a recombinant form of the C-terminal, globular head region of the B-chain of human serum complement protein, C1q.
    Kishore U; Leigh LE; Eggleton P; Strong P; Perdikoulis MV; Willis AC; Reid KB
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):27-32. PubMed ID: 9639558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Von Willebrand Factor Interacts with Surface-Bound C1q and Induces Platelet Rolling.
    Kölm R; Schaller M; Roumenina LT; Niemiec I; Kremer Hovinga JA; Khanicheh E; Kaufmann BA; Hopfer H; Trendelenburg M
    J Immunol; 2016 Nov; 197(9):3669-3679. PubMed ID: 27698012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Suppression of thrombocyte aggregation by immune complexes. II. The effect of preformed immune complexes on thrombocyte aggregation].
    Osipov SG; Turlubekov KK; Titov VN; Rudnev VI; Shkhvatsabaia IK
    Biull Eksp Biol Med; 1983 Feb; 95(2):21-3. PubMed ID: 6824768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free platelet count and size distribution during C1q inhibition of collagen-induced platelet aggregation.
    Csako G; Suba EA
    Thromb Haemost; 1987 Aug; 58(2):682-5. PubMed ID: 3499680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Porcine C1q and the solid-phase immunoassay of human immune complexes.
    Ziola B; Salmi A; Penttinen K
    J Immunol Methods; 1982 Mar; 49(3):247-60. PubMed ID: 6978362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.